AAAAAA
Results: 26-42/42
Authors:
Matthews, GV
Bower, M
Mandalia, S
Powles, T
Nelson, MR
Gazzard, BG
Citation: Gv. Matthews et al., Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy, BLOOD, 96(8), 2000, pp. 2630-2634
Authors:
Matthews, GV
Bower, M
Mandalia, S
Powles, T
Nelson, MR
Gazzard, BG
Citation: Gv. Matthews et al., Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy, BLOOD, 96(8), 2000, pp. 2730-2734
Authors:
Gazzard, BG
Citation: Bg. Gazzard, Efavirenz in the management of HIV infection, INT J CL PR, 53(1), 1999, pp. 60-64
Authors:
Gazzard, BG
Moyle, G
Citation: Bg. Gazzard et G. Moyle, Commentary: Resistance testing - a clinical perspective, SEX TRANS I, 75(3), 1999, pp. 141-142
Authors:
Bower, M
Fife, K
Sullivan, A
Kirk, S
Phillips, RH
Nelson, M
Gazzard, BG
Citation: M. Bower et al., Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma, EUR J CANC, 35(4), 1999, pp. 601-604
Authors:
Sullivan, AK
Hannan, MM
Azadian, BS
Easterbrook, PJ
Gazzard, BG
Nelson, MR
Citation: Ak. Sullivan et al., Acid-alcohol fast bacilli in sputa of HIV-infected patients, INT J STD A, 10(9), 1999, pp. 606-608
Authors:
Easterbrook, PJ
Goodall, RL
Babiker, AG
Yu, LM
Smith, D
Cooper, DA
Gazzard, BG
Citation: Pj. Easterbrook et al., Are HIV-infected patients with rapid CD4 cell decline a subgroup who benefit from early antiretroviral therapy?, J ANTIMICRO, 43(3), 1999, pp. 379-388
Authors:
Cartledge, JD
Midgley, J
Gazzard, BG
Citation: Jd. Cartledge et al., Non-albicans oral candidosis in HIV-positive patients, J ANTIMICRO, 43(3), 1999, pp. 419-422
Authors:
Miao, YM
Awad-El-Kariem, FM
Gibbons, CL
Gazzard, BG
Citation: Ym. Miao et al., Cryptosporidiosis: eradication or suppression with combination antiretroviral therapy?, AIDS, 13(6), 1999, pp. 734-735
Authors:
Babiker, AG
Darbyshire, JH
Gazzard, BG
Hooker, MH
Kitchen, V
Newberry, A
Peto, TE
Tedder, R
Weber, J
Breckenridge, A
Back, D
Blatchford, N
Gartland, M
Jeffries, D
Johnson, M
Plummer, K
Wills, B
Loveday, C
Weller, IVD
Withnall, R
Citation: Ag. Babiker et al., A randomized trial comparing regimens of four reverse transcriptase inhibitors given together or cyclically in HIV-1 infection - The Quattro Trial, AIDS, 13(16), 1999, pp. 2209-2217
Authors:
Paton, NI
Newton, PJ
Sharpstone, DR
Ross, HM
Cotton, J
Calder, AG
Milne, E
Elia, M
Shah, S
Engrand, P
Macallan, DC
Gazzard, BG
Griffin, GE
Citation: Ni. Paton et al., Short-term growth hormone administration at the time of opportunistic infections in HIV-positive patients, AIDS, 13(10), 1999, pp. 1195-1202
Authors:
Davis, PA
Corless, DJ
Gazzard, BG
Wastell, C
Citation: Pa. Davis et al., Increased risk of wound complications and poor healing following laparotomy in HIV-seropositive and AIDS patients, DIGEST SURG, 16(1), 1999, pp. 60-67
Authors:
Moyle, GJ
Gazzard, BG
Citation: Gj. Moyle et Bg. Gazzard, A risk-benefit assessment of HIV protease inhibitors, DRUG SAFETY, 20(4), 1999, pp. 299-321
Authors:
Easterbrook, PJ
Rostron, T
Ives, N
Troop, M
Gazzard, BG
Rowland-Jones, SL
Citation: Pj. Easterbrook et al., Chemokine receptor polymorphisms and human immunodeficiency virus disease progression, J INFEC DIS, 180(4), 1999, pp. 1096-1105
Authors:
Hayes, PJ
Miao, YM
Gotch, FM
Gazzard, BG
Citation: Pj. Hayes et al., Alterations in blood leucocyte adhesion molecule profiles in HIV-1 infection, CLIN EXP IM, 117(2), 1999, pp. 331-334
Authors:
Mitchell, SM
Membrey, WL
Youle, MS
Obi, A
Worrell, S
Gazzard, BG
Citation: Sm. Mitchell et al., Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study, BR J OPHTH, 83(6), 1999, pp. 652-655
Authors:
Smith, NP
Nelson, MR
Azadian, B
Gazzard, BG
Citation: Np. Smith et al., An outbreak of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-seropositive persons, INT J STD A, 9(12), 1998, pp. 726-730